56 related articles for article (PubMed ID: 1801101)
21. Effect of aztreonam on immunohistochemical localizations of cytochrome P-450 (M-1) in male rats.
Sagami F; Tsukidate K; Fukuda T; Hayashi S; Horie T
Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):337-44. PubMed ID: 2813957
[TBL] [Abstract][Full Text] [Related]
22. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
23. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
Jeffery EH; Mannering GJ
Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
[TBL] [Abstract][Full Text] [Related]
24. Computer prediction and experimental validation of cytochrome P4502D6-dependent oxidation of GBR 12909.
de Groot MJ; Bijloo GJ; Hansen KT; Vermeulen NP
Drug Metab Dispos; 1995 Jun; 23(6):667-9. PubMed ID: 7587951
[No Abstract] [Full Text] [Related]
25. Inhibition and induction of cytochrome P450 isozymes after repetitive administration of imipramine in rats.
Masubuchi Y; Takahashii C; Fujio N; Horie T; Suzuki T; Imaoka S; Funae Y; Narimatsu S
Drug Metab Dispos; 1995 Sep; 23(9):999-1003. PubMed ID: 8565792
[TBL] [Abstract][Full Text] [Related]
26. In vitro formation of an inhibitory complex between an isosafrole metabolite and rat hepatic cytochrome P-450 PB-B.
Murray M; Reidy GF
Drug Metab Dispos; 1989; 17(4):449-54. PubMed ID: 2571488
[TBL] [Abstract][Full Text] [Related]
27. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine.
Prough RA; Brown MI; Dannan GA; Guengerich FP
Cancer Res; 1984 Feb; 44(2):543-8. PubMed ID: 6692359
[TBL] [Abstract][Full Text] [Related]
28. Drug-induced hepatotoxicity.
Fenichel RR
N Engl J Med; 1996 Mar; 334(13):864. PubMed ID: 8596562
[No Abstract] [Full Text] [Related]
29. Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4'-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases.
Butler MA; Guengerich FP; Kadlubar FF
Cancer Res; 1989 Jan; 49(1):25-31. PubMed ID: 2908851
[TBL] [Abstract][Full Text] [Related]
30. Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives.
Bach MV; Coutts RT; Baker GB
Xenobiotica; 1999 Jul; 29(7):719-32. PubMed ID: 10456690
[TBL] [Abstract][Full Text] [Related]
31. Evidence in humans for variant allozymes of the nondeficient sparteine/debrisoquine monooxygenase (P45OIID 1) in vitro.
Tyndale RF; Inaba T; Kalow W
Drug Metab Dispos; 1989; 17(3):334-40. PubMed ID: 2568917
[TBL] [Abstract][Full Text] [Related]
32. Fenproporex N-dealkylation to amphetamine--enantioselective in vitro studies in human liver microsomes as well as enantioselective in vivo studies in Wistar and Dark Agouti rats.
Kraemer T; Pflugmann T; Bossmann M; Kneller NM; Peters FT; Paul LD; Springer D; Staack RF; Maurer HH
Biochem Pharmacol; 2004 Sep; 68(5):947-57. PubMed ID: 15294457
[TBL] [Abstract][Full Text] [Related]
33. Stereoselective genetically-determined interaction between chronic flecainide and quinidine in patients with arrhythmias.
Birgersdotter UM; Wong W; Turgeon J; Roden DM
Br J Clin Pharmacol; 1992 Mar; 33(3):275-80. PubMed ID: 1576047
[TBL] [Abstract][Full Text] [Related]
34. Quinidine inhibits in vivo metabolism of amphetamine in rats: impact upon correlation between GC/MS and immunoassay findings in rat urine.
Moody DE; Ruangyuttikarn W; Law MY
J Anal Toxicol; 1990; 14(5):311-7. PubMed ID: 2263067
[TBL] [Abstract][Full Text] [Related]
35. Effect of iprindole on the metabolism of trimipramine in the rat.
Coutts RT; Hussain MS; Baker GB
J Psychiatry Neurosci; 1991 Dec; 16(5):272-5. PubMed ID: 1797102
[TBL] [Abstract][Full Text] [Related]
36. In vivo metabolism of N-alkylamphetamines in the rat--the effect of N-alkyl chain length on oxidation of the aromatic ring.
Coutts RT; Dawson GW; Jones GR
Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):589-92. PubMed ID: 734236
[TBL] [Abstract][Full Text] [Related]
37. A dehydrogenase system to demonstrate oxidation of amphetamine and related compounds by rat brain homogenate.
Ghosh SK; Guha SR
Indian J Physiol Pharmacol; 1977; 21(2):137-40. PubMed ID: 885599
[TBL] [Abstract][Full Text] [Related]
38. Effects of quinidine and cimetidine on the methamphetamine level in the rat brain.
Suzuki T; Chiang HJ; Misawa M
Jpn J Pharmacol; 1987 Jan; 43(1):103-6. PubMed ID: 3573415
[TBL] [Abstract][Full Text] [Related]
39. A possible cytochrome P-450-mediated N-oxidation of diethylcarbamazine.
Joseph CA; Dixon PA
J Pharm Pharmacol; 1984 Oct; 36(10):711-2. PubMed ID: 6150098
[TBL] [Abstract][Full Text] [Related]
40. Effect of sparteine and quinidine on the metabolism of methoxyphenamine by Cunninghamella bainieri.
Foster BC; Wilson DL; McGilveray IJ
Xenobiotica; 1989 Apr; 19(4):445-52. PubMed ID: 2750204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
